Ludwig Enterprises, Inc. Stock News

Ludwig's genomic-based mRNA Inflammatory Index - a Ground-Breaking Technology   Sparks, NV -- September 28, 2022 -- InvestorsHub NewsWire -- (OTC PINK:LUDG) Ludwig Enterprises, a leading-edge innovator of genetic inflammatory biomarkers to diagnose and manage chronic diseases, is pleased to announce more detail on this crucial technology, cooperative contracts, and current applications. This technology's potential medical and commercial value is revealed in a Re...

Ludwig Files A Patent That Could Be a Major Technology Breakthrough in Healthcare Ludwig Enterprises Files Messenger Ribonucleic Acid (mRNA) Patent - Ludwig mRNA Inflammatory Index™     SPARKS, NV -- September 22, 2022 -- InvestorsHub NewsWire -- (OTC PINK:LUDG) Ludwig Enterprises, a leading-edge innovator of genetic inflammatory biomarkers to diagnose and manage chronic diseases, is pleased to announce that the Company has filed a patent on proprietary t...

Ludwig Enterprises and Emerson Urology Associates Plan Bladder Cancer BCG Immunotherapy Study Ludwig Prepares Major Patent Filing     SPARKS, NV -- September 20, 2022 -- InvestorsHub NewsWire -- (OTC PINK:LUDG)  Ludwig Enterprises, a leading-edge innovator of genetic inflammatory biomarkers to diagnose and manage chronic diseases,  is pleased to announce that the Company has started discussions with Emerson Urology Associates, Concord, MA regarding in...